August 2024 - Conference Time!

Banu İyisan gave a talk about our recent research on designing versatile hybrid nanoparticles as cancer therapeutics at the American Chemical Society (ACS) Fall 2024 conference, in the 'Biomaterials and Biointerfaces session.